Small molecule inhibitors targeting cyclin-dependent kinases as anticancer agents
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology
Link
http://link.springer.com/content/pdf/10.1007/s11912-004-0024-3.pdf
Reference58 articles.
1. Rudek MA, Bauer KS Jr, Lush RM III, et al.: Clinical pharmacology of flavopiridol following a 72-hour continuous infusion. Ann Pharmacother 2003, 37:1369–1374.
2. Aklilu M, Kindler HL, Donehower RC, et al.: Phase II study of flavopiridol in patients with advanced colorectal cancer. Ann Oncol 2003, 14:1270–1273.
3. Zhai S, Sausville EA, Senderowicz AM, et al.: Clinical pharmacology and pharmacogenetics of flavopiridol 1-h I.v. infusion in patients with refractory neoplasms. Anticancer Drugs 2003, 14:125–135.
4. Kouroukis CT, Belch A, Crump M, et al.: Flavopiridol in untreated or relapsed mantle-cell lymphoma: results of a phase II study of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 2003, 21:1740–1745.
5. Sedlacek HH: Mechanisms of action of flavopiridol. Crit Rev Oncol Hematol 2001, 38:139–170.
Cited by 49 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Biocompatible silver(I) complexes with heterocyclic thioamide ligands for selective killing of cancer cells and high antimicrobial activity – A combined in vitro and in silico study;Journal of Inorganic Biochemistry;2022-03
2. Cell cycle deregulation in neurodegenerative diseases;International Journal of Neuroscience;2021-09-27
3. Silver complexes with heterocyclic thioamide and tertiary arylphosphane ligands: Synthesis, crystal structures, in vitro and in silico antibacterial and cytotoxic activity, and interaction with DNA;Journal of Inorganic Biochemistry;2020-09
4. Stabilization of primary cilia reduces abortive cell cycle re-entry to protect injured adult CNS neurons from apoptosis;PLOS ONE;2019-08-01
5. Natural Compounds as Modulators of Cell Cycle Arrest: Application for Anticancer Chemotherapies;Current Genomics;2017-01-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3